Quantitative Systematic Strategies’s Select Medical SEM Stock Holding History

Quantitative Systematic Strategies’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-69,561	Closed	-$680K	–	772
2018 Q2	$680K	Buy	+69,561	New	+$683K	0.12%	273
2016 Q2	–	Sell	-24,108	Closed	-$151K	–	506
2016 Q1	$151K	Buy	+24,108	New	+$129K	0.06%	340

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Quantitative Systematic Strategies's SEM Position: Q3 2018 in Review

Quantitative Systematic Strategies sold out of Select Medical (SEM) in Q3 2018, closing a stake of 69,561 shares — an estimated $680K sold.

Quantitative Systematic Strategies first reported a position in SEM in Q1 2016 and held it in 2 quarters. The position peaked at $680K in Q2 2018. 197 funds tracked by Wall St. Rank hold SEM as of Q3 2018.

Quantitative Systematic Strategies reported no remaining Select Medical position as of Q3 2018 after selling out during the quarter.
Quantitative Systematic Strategies sold 69,561 Select Medical shares in Q3 2018, an estimated $680K.
Quantitative Systematic Strategies first reported a position in Select Medical in Q1 2016 and held it in 2 quarters.
Quantitative Systematic Strategies's Select Medical position peaked at $680K in Q2 2018.
197 funds tracked by Wall St. Rank held Select Medical as of Q3 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.